Skip to search.
 BSE Up 0.51% NSE Up 0.56%

More On AEZS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Aeterna Zentaris Inc. (AEZS)

-NasdaqCM
0.19 Down 0.01(6.72%) 30 Jul 1:29am
Add to Portfolio
Prev Close:0.20
Open:0.20
Bid:N/A
Ask:0.37 x 200
1y Target Est:1.43
Beta:1.77
Next Earnings Date:N/A
Day's Range:0.18 - 0.21
52wk Range:0.18 - 1.54
Volume:6,617,879
Avg Vol (3m):4,250,220
Market Cap:17.84M
P/E (ttm):N/A
EPS (ttm):-0.35
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for AEZS at this time.

Comparison

Symbol% ChgMkt Cap
AEZSDown 6.72%17.84M
CELGDown 2.42%104.81B
ENMD 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):227.64
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.33
Quarterly EPS Est (Jun-15) :-0.08
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback